Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 antibody Rituximab.

被引：0
|
作者：
Giagounidis, AAN
Anhuf, J
Schneider, P
Germing, U
Soehngen, D
Quabeck, K
Aul, C
机构：
[1] St Johannes Hosp, Med Klin 2, Duisburg, Germany
[2] Univ Dusseldorf, Med Klin A, Dusseldorf, Germany
[3] Univ Cologne, Innere Med Klin 1, Cologne, Germany
[4] Haemato Onkol Schwerpunktpraxis, Duisburg, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2187
引用
收藏
页码：523A / 523A
页数：1
相关论文
共 50 条
  • [1] Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab:: a pilot study
    Giagounidis, AAN
    Anhuf, J
    Schneider, P
    Germing, U
    Söhngen, D
    Quabeck, K
    Aul, C
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (02) : 95 - 100
  • [2] Retreatment of 11 patients with immune thrombocytopenic purpura with the anti-CD20 monoclonal antibody, rituximab.
    Cooper, N
    Stasi, R
    Michel, M
    Bussel, JB
    BLOOD, 2003, 102 (11) : 86B - 86B
  • [3] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
    Stasi, R
    Pagano, A
    Stipa, E
    Amadori, S
    BLOOD, 2001, 98 (04) : 952 - 957
  • [4] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura
    Brændstrup, P
    Bjerrum, OW
    Nielsen, OJ
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Andersen, I
    Schmidt, K
    Andersen, TM
    Peterslund, NA
    Birgens, HS
    Plesner, T
    Pedersen, BB
    Hasselbalch, HC
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) : 275 - 280
  • [5] Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with refractory idiopathic thrombocytopenic purpura.
    Braendstrup, P
    Pedersen, M
    Bjerrum, OW
    Nielsen, OJ
    Jensen, BA
    Clausen, NT
    Hansen, PB
    Andersen, I
    Schmidt, K
    Andersen, TM
    Peterslund, NA
    Birgens, HS
    Plesner, T
    Pedersen, BB
    Hasselbalch, HC
    BLOOD, 2003, 102 (11) : 298A - 298A
  • [6] Rituximab: An anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura
    Aggarwal, A
    Catlett, JP
    SOUTHERN MEDICAL JOURNAL, 2002, 95 (10) : 1209 - 1212
  • [7] Resistant idiopathic thrombocytopenic purpura - Treatment with rituximab.
    Saouli, Zoi
    Papadopoulos, Athanasios
    Kaiafa, Georgia
    Charisopoulos, Georg
    Kontoninas, Zisis
    Margaritidis, Charalambos
    Girtovitis, Folios
    BLOOD, 2006, 108 (11) : 69B - 69B
  • [8] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [9] Single dose of Anti-CD20 monoclonal antibody (rituximab) treatment in adults with refractory immune thrombocytopenic purpura (ITP).
    Tanaka, Eri
    Hayashi, Shuji
    Fujimaki, Katsumichi
    Fujita, Hiroyuki
    BLOOD, 2006, 108 (11) : 321A - 321A
  • [10] Anti-CD20 monoclonal antibody (rituximab) administration in patients with refractory immunologic thrombocytopenic purpura.
    Rosenthal, E
    Karsenti, JM
    Pesce, A
    Cassuto, JP
    BLOOD, 2001, 98 (11) : 525A - 525A
12345